These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2404714)

  • 21. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
    Kamath V; Jones CN; Yip JC; Varasteh BB; Cincotta AH; Reaven GM; Chen YD
    Diabetes Care; 1997 Nov; 20(11):1697-701. PubMed ID: 9353611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
    Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
    Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes.
    Santos RF; Nomizo R; Wajhenberg BL; Reaven GM; Azhar S
    Diabete Metab; 1995 Oct; 21(4):274-80. PubMed ID: 8529763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
    Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
    J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.
    Fanghänel G; Sánchez-Reyes L; Trujillo C; Sotres D; Espinosa-Campos J
    Diabetes Care; 1996 Nov; 19(11):1185-9. PubMed ID: 8908377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.
    Prager R; Schernthaner G; Graf H
    Diabete Metab; 1986 Dec; 12(6):346-50. PubMed ID: 3817257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?
    Chen YD; Coulston AM; Zhou MY; Hollenbeck CB; Reaven GM
    Diabetes Care; 1995 Jan; 18(1):10-6. PubMed ID: 7698030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM.
    Gannon MC; Ercan N; Westphal SA; Nuttall FQ
    Diabetes Care; 1993 Jun; 16(6):874-80. PubMed ID: 8325201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity.
    Jenney A; Proietto J; O'Dea K; Nankervis A; Traianedes K; D'Embden H
    Diabetes Care; 1993 Feb; 16(2):499-502. PubMed ID: 8432223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.
    Nagi DK; Yudkin JS
    Diabetes Care; 1993 Apr; 16(4):621-9. PubMed ID: 8462390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients.
    Vessby B; Boberg M; Hellsing K; Lithell H; Berne C
    Diabetes Res; 1989 Nov; 12(3):109-16. PubMed ID: 2699585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM.
    Jones IR; Swai A; Taylor R; Miller M; Laker MF; Alberti KG
    Diabetes Care; 1990 Aug; 13(8):855-63. PubMed ID: 2209320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.
    Sambol NC; Chiang J; O'Conner M; Liu CY; Lin ET; Goodman AM; Benet LZ; Karam JH
    J Clin Pharmacol; 1996 Nov; 36(11):1012-21. PubMed ID: 8973990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.
    Hermann LS; Scherstén B; Bitzén PO; Kjellström T; Lindgärde F; Melander A
    Diabetes Care; 1994 Oct; 17(10):1100-9. PubMed ID: 7821128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
    Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
    Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
    Shelgikar KM; Naik SS; Khopkar M; Bhat DS; Raut KN; Joglekar CV; Gerard ME; Yajnik CS
    Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.